Mandate

Vinge represented sellers when Polhem acquired shares in Solör

November 21, 2019

Vinge represented the sellers Meritor, Inc. Retirement Plan, Sunrise BE I, LLC and YRC Worldwide, Inc. Master Pension Plans Trust in their divestment of shares in Solör Bioenergi Holding AB (”Solör”) to Polhem Infra KB (”Polhem”).

Solör is a privately‑owned energy company with focus on sustainable district heating in Sweden and Norway. Polhem is an investment company wholly‑owned by the Swedish State Pension Funds AP1, AP3 and AP4. In the acquisition, which also involved BE Bio Energy Group AG on the sell‑side, Polhem acquired a total of 21.45 percent of the shares in Solör.

Vinges team comprised Johan Göthberg, Maria Dahlin Kolvik, Hanna Risberg and Agnes Widlund (trainee).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025